Physician profile
Kachon Lei
NPI 1558868992
$9,739.41
in general payments reported to CMS, 2019-2025
29 companies · $3,698 in 2025
The $3,698 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $392 · 2023: $1,816 · 2024: $3,833 · 2025: $3,698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,337 · Education: $898 · Consulting Fee: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,336.82 |
| Education | $898.11 |
| Consulting Fee | $112.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,675.68 | 2023-2025 | Aveir, Gallant, Cardiomems |
| Medtronic, INC. | $1,504.04 | 2024-2025 | Onyx Frontier, Symplicity G3, Ffrangio |
| Abiomed | $950.57 | 2023-2025 | Impella |
| Biosense Webster, INC. | $658.35 | 2023-2025 | Carto 3, Visitag Surpoint External Processing Unit, Qdot Micro |
| Shockwave Medical, INC | $626.79 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lantheus Medical Imaging, INC. | $624.83 | 2022-2025 | Definity |
| E.R. Squibb & Sons, L.L.C. | $587.16 | 2023-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $460.84 | 2023-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $309.90 | 2024-2025 | Assure Wcd |
| Novo Nordisk INC | $225.65 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Astellas Pharma US INC | $198.99 | 2023 | |
| Pfizer INC. | $187.83 | 2023-2025 | |
| Boston Scientific Corporation | $186.98 | 2024-2025 | Watchman Access System, Watchman Flx |
| Alnylam Pharmaceuticals INC. | $177.29 | 2022-2025 | Amvuttra |
| Lexicon Pharmaceuticals, INC. | $146.25 | 2024 | Inpefa |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $143.68 | 2022 | |
| Cook Medical LLC | $137.13 | 2025 | Rosen |
| Merck Sharp & Dohme LLC | $136.61 | 2025 | Winrevair, Verquvo |
| Edwards Lifesciences Corporation | $132.00 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Philips North America LLC | $126.95 | 2025 | Igt Devices Undivided |
| Scpharmaceuticals INC. | $120.06 | 2025 | |
| Novartis Pharmaceuticals Corporation | $92.04 | 2024-2025 | |
| Chiesi USA, INC. | $83.64 | 2023 | Kengreal |
| Janssen Pharmaceuticals, INC | $75.22 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.91 | 2023-2024 | Jardiance |
| Bridgebio Pharma, INC. | $53.31 | 2025 | Attruby |
| Acist Medical Systems, INC. | $35.13 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $13.59 | 2025 | Farxiga |
| Cardiovascular Systems INC. | $11.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kachon Lei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.